JPS5653101A - Polysaccharide ks-2-d and its preparation - Google Patents
Polysaccharide ks-2-d and its preparationInfo
- Publication number
- JPS5653101A JPS5653101A JP12073679A JP12073679A JPS5653101A JP S5653101 A JPS5653101 A JP S5653101A JP 12073679 A JP12073679 A JP 12073679A JP 12073679 A JP12073679 A JP 12073679A JP S5653101 A JPS5653101 A JP S5653101A
- Authority
- JP
- Japan
- Prior art keywords
- average
- molecular weight
- water
- polysaccharide
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
NEW MATERIAL:A polysaccharide, KS-2-D, having the following physical and chemical properties. Elemental analysis, C 42.3±1.5%, H 6.2±0.3%, N 0.6± 0.2%, ash 6.7± 2.5%; molecular weight, 30,000W70,000, average molecular weight, 70,000; white amorphous powder; decomposition point, 185°C (Capillary method); pH=7W8, nearly neutral; soluble in water, insoluble in ethanol, acetone, n-hexane, etc.; specific rotation, [α]D21=+66.1W+97.5° (average 82.9°) (water, c=0.5%); positive to phenol-sulfuric acid reaction, anthron reaction, etc., negative to toluidine blue O staining; saccharide content, 65W80% (average 71%), protein content, 3.5W6% (average 4.8%), protein/saccharide ratio, 0.05W0.08 (average 0.07), etc.
USE: Carcinostatic agent. Preventive and remedy for diseases caused by candida, Pseudomonas aeruginosa, Listeria, influenza virus, etc.
PROCESS: The compound can be prepared by culturing strain of Lentinus edodes KSLE 28 (FERM-P No.4196), etc.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12073679A JPS5653101A (en) | 1979-09-21 | 1979-09-21 | Polysaccharide ks-2-d and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12073679A JPS5653101A (en) | 1979-09-21 | 1979-09-21 | Polysaccharide ks-2-d and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5653101A true JPS5653101A (en) | 1981-05-12 |
Family
ID=14793706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12073679A Pending JPS5653101A (en) | 1979-09-21 | 1979-09-21 | Polysaccharide ks-2-d and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5653101A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1774012A2 (en) * | 2004-07-16 | 2007-04-18 | Medimush A/S | Immune modulating compounds from fungi |
| US7514085B2 (en) | 2004-07-16 | 2009-04-07 | Medimush A/S | Immune modulating compounds from fungi |
| US10471135B2 (en) | 2001-09-03 | 2019-11-12 | Glycanova As | Production of fungal extracellular immune stimulating compounds |
-
1979
- 1979-09-21 JP JP12073679A patent/JPS5653101A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10471135B2 (en) | 2001-09-03 | 2019-11-12 | Glycanova As | Production of fungal extracellular immune stimulating compounds |
| EP1774012A2 (en) * | 2004-07-16 | 2007-04-18 | Medimush A/S | Immune modulating compounds from fungi |
| US7514085B2 (en) | 2004-07-16 | 2009-04-07 | Medimush A/S | Immune modulating compounds from fungi |
| US7682615B2 (en) | 2004-07-16 | 2010-03-23 | Beka Holding As | Immune modulating compounds from fungi |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR890007722A (en) | Pharmaceutical composition containing excipon and demand polymer | |
| AU550317B2 (en) | Polysaccharide anti-thromboticum | |
| JPS5653101A (en) | Polysaccharide ks-2-d and its preparation | |
| FR2570081B1 (en) | MEMBRANE POLYSACCHARIDES USEFUL IN PARTICULAR AS A MEDICAMENT AND PROCESS FOR THEIR PREPARATION | |
| JPS5634701A (en) | Beta-1,3-glucan, its preparation and use | |
| WO1991010435A1 (en) | Chitosan pyrithione as antimicrobial agent useful in personal care products | |
| ES8106835A1 (en) | Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents. | |
| US4009264A (en) | Complexes of polysaccharides or derivatives thereof with reduced glutathione and process for preparing said complexes | |
| ATE17954T1 (en) | MUTASTEIN, PHYSIOLOGICALLY ACTIVE SUBSTANCE AND PROCESS OF PRODUCTION. | |
| GB1393427A (en) | Rodenticides and process for their preparation | |
| Nicklin et al. | Intestinal uptake of carrageenan: distribution and effects on humoral immune competence | |
| JPS57139091A (en) | Carcinostatic substance tv-130, its preparation and carcinostatic agent containing the same | |
| JPS55709A (en) | Novel polysaccharide and its use | |
| SU929015A3 (en) | Process for producing polysaccharide | |
| JPS57117503A (en) | High polymeric polysaccharide substance mps-80 and its preparation | |
| JPS5527101A (en) | Preventive and remedy for infectious diseases | |
| JPS5571702A (en) | Antitumorous glucan derivative, its preparation, and carcinostatic substance containing it | |
| JPS5794001A (en) | Novel polysaccharide | |
| JPH01186813A (en) | Substance having glucosyl transferase inhibiting activity | |
| JPS61225125A (en) | Antitumor agent | |
| JPS54108828A (en) | Coating composition of fluorescent substance | |
| JPS5718969A (en) | Preparation of organic complex from essential nutrient metallic element | |
| JPS57139088A (en) | Carcinostatic substance tf-340, its preparation and carcinostatic agent containing the same | |
| JPS5732297A (en) | Carcinostatic substance tf-150, its preparation, and carcinostatic agent containing the same | |
| JPS5590517A (en) | Water-containing gel |